Novel humanized monoclonal antibodies, humanized antibody fragments, and
derivatives thereof which specifically bind TAG-72 are provided as well as
methods for their manufacture. These humanized antibodies are useful in
the treatment of cancers which express TAG-72 as well as for diagnostic
purposes, e.g., for in vivo imaging of tumors or cancer cells which
express TAG-72.